Abstract
Objectives The main objective of this study was to compare neutrophil-lymphocyte ratio, a marker of systemic inflammation, between patients diagnosed with ICD-10 psychiatric disorders and control participants.
Design A cross-sectional methodology was employed to retrospectively analyse electronic health records and records derived from a national health survey.
Setting A secondary mental health care service consisting of four boroughs in South London.
Participants A diverse sample of 13,888 psychiatric patients extracted from South London and Maudsley electronic health records database and 3,920 control participants extracted from National Health and Nutrition Survey (2015-2016) were included in the study.
Primary and secondary outcome measures Primary: NLR levels in patients with mental health diagnoses, NLR between patients with different mental health diagnoses. Secondary: Relationship of NLR to length of hospitalisation and to mortality.
Results NLR was elevated compared to controls in patients with diagnoses including dementia, alcohol dependence, schizophrenia, bipolar affective disorder, depression, non-phobic anxiety disorders, and mild mental retardation (p < 0.05). NLR also correlated with age, antipsychotic use and hypnotic use. NLR was found to be higher in individuals of “White” ethnicity and lower in individuals of “Black” ethnicity. Elevated NLR was associated with increased mortality (β = 0.103, p = 2.9e-08) but not with hospital admissions or face-to-face contacts.
Conclusions Elevated NLR may reflect a transdiagnostic pathological process occurring in a subpopulation of psychiatric patients. NLR may be useful to identify and stratify patients who could benefit from adjunctive anti-inflammatory treatment.
Strengths and limitations of this study
Largest study to date of cross-diagnostic neutrophil-lymphocyte measurements in a psychiatric population.
Sample is representative of diverse adult psychiatric patients in South London.
Systematic differences between patients and controls reduce the validity of these comparisons.
This study was retrospective and thus, confounding measures such as body mass index, smoking status and diet were unavailable.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This paper represents independent research funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of Interest The authors report no conflict of interest.
Financial Support This paper represents independent research funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.
Data Sharing Statement Because of their clinical source and under the terms of Ethics and Information Governance approvals, datasets derived from CRIS have to remain within the SLaM firewall. However, all data used for this study will be made accessible on request to cris.administrator{at}slam.nhs.uk subject to setting up an appropriate SLaM honorary contract or research passport.
Data Availability
No additional data is available
